Veri Medtech Holdings (VRHI) Income Statement
Veri Medtech Holdings Income Statement
Last quarter (Q2 2026), Veri Medtech Holdings's total revenue was $2.04M, a decrease of 28.60% from the same quarter last year. In Q2, Veri Medtech Holdings's net income was $-296.23K. See Veri Medtech Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 10.85M | $ 16.65M | $ 78.13K | $ 25.17K | $ 49.30K | |
| $ 8.17M | $ 12.39M | $ 66.79K | $ 20.90K | $ 37.73K | |
| $ 10.43M | $ 12.69M | $ 128.71K | $ 60.34K | $ 70.25K | |
| Depreciation and Amortization | $ 113.87K | $ 102.80K | $ 1.96K | $ 490.00 | $ 1.47K |
| $ -2.15M | $ -199.50K | $ -59.96K | $ -38.95K | $ -31.05K | |
| $ -2.27M | $ -302.30K | $ -61.92K | $ -39.44K | $ -224.16K | |
| $ -69.05K | $ -106.51K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -2.34M | $ -408.81K | $ -61.92K | $ -39.44K | $ -32.52K | |
| $ -2.34M | $ -408.81K | $ -61.92K | $ -39.44K | $ -32.52K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.30 | $ -0.09 | $ -0.00 | $ -0.00 | $ -0.01 |
| Diluted EPS | $ -0.30 | $ -0.09 | $ -0.00 | $ -0.00 | $ -0.01 |
| Weighted Average Shares Outstanding | 7.99M | 4.60M | 22.24M | 22.24M | 20.24M |
| Weighted Average Shares Outstanding (Diluted) | 7.99M | 4.60M | 22.24M | 22.24M | 20.24M |
Currency in USD